Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.2K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A transcriptional patient map of systemic lupus erythematosus reveals disease-related multicellular immune programs conserved between blood and kidney.

bioRxiv : the preprint server for biology·2026
Same author

Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications.

Dermatology and therapy·2026
Same author

Publisher Correction: Interpretable inflammation landscape of circulating immune cells.

Nature medicine·2026
Same author

Interpretable inflammation landscape of circulating immune cells.

Nature medicine·2026
Same author

Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity.

Nature communications·2025
Same author

Fecal microbiome analysis in patients with metabolic syndrome and type 2 diabetes.

PeerJ·2025
Same journal

DARUMA: a gateway to fast and easy prediction of intrinsically disordered regions.

PeerJ. Computer science·2026
Same journal

Alzheimer's disease detection using a quantum deep neural network with Haralick feature extraction and simulated annealing optimization.

PeerJ. Computer science·2026
Same journal

Network anomaly detection using Deep Autoencoder and parallel Artificial Bee Colony algorithm-trained neural network.

PeerJ. Computer science·2026
Same journal

An anomaly detection model for multivariate time series with anomaly perception.

PeerJ. Computer science·2026
Same journal

Retraction: A wormhole attack detection method for tactical wireless sensor networks.

PeerJ. Computer science·2026
Same journal

Evaluation of mental disorder with prioritization of its type by utilizing the bipolar complex fuzzy decision-making approach based on Schweizer-Sklar prioritized aggregation operators.

PeerJ. Computer science·2026
See all related articles

Related Experiment Video

Updated: Oct 26, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

510

Machine learning analysis of TCGA cancer data.

Jose Liñares-Blanco1,2, Alejandro Pazos1,2,3, Carlos Fernandez-Lozano1,2,3

  • 1CITIC-Research Center of Information and Communication Technologies, University of A Coruna, A Coruña, Spain.

Peerj. Computer Science
|July 29, 2021
PubMed
Summary
This summary is machine-generated.

Machine learning (ML) is increasingly applied to cancer research using The Cancer Genome Atlas (TCGA) data. This review classifies ML studies by tumor type, algorithm, and biological problem, highlighting trends in data usage and popular methods.

Keywords:
BRCACancerData integrationMachine learningMulti-omicsRandom ForestSupport Vector MachinesTCGA

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.8K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.2K

Related Experiment Videos

Last Updated: Oct 26, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

510
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.8K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.2K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Machine learning (ML) is gaining traction in analyzing complex biological problems.
  • Large-scale initiatives like The Cancer Genome Atlas (TCGA) provide omic data for ML model training.
  • Standard analytical approaches are often insufficient for intricate biological data.

Purpose of the Study:

  • To review and classify existing literature on ML applications using TCGA data.
  • To identify key trends, popular algorithms, and biological problems addressed.
  • To provide a foundation for future research in ML for cancer genomics.

Main Methods:

  • Systematic review of over 100 research papers utilizing TCGA data for ML model training.
  • Classification of studies based on tumor type, ML algorithm employed, and the biological question investigated.
  • Analysis of data types used, with a focus on gene expression data.

Main Results:

  • Random Forest and Support Vector Machines are dominant ML algorithms, with a rise in deep neural networks.
  • Integrative multi-omic data analysis models are increasingly utilized.
  • Gene expression data is the most frequently used data type for training ML models.

Conclusions:

  • ML is a powerful tool for dissecting cancer genomics, leveraging TCGA data.
  • Specific tumor types (e.g., BRCA) and biological problems (e.g., survival prediction in GBM) show distinct research trends.
  • This review consolidates the state-of-the-art, guiding future ML-driven cancer research.